Cadrenal Therapeutics Inc
XNAS:CVKD 3:30:37 PM EDT
Cadrenal Therapeutics Inc Stock, XNAS:CVKD
822 A1A North, Suite 306, Ponte Vedra Beach, Florida 32082
United States of America
Phone: +1.904.300.0701
Number of Employees: 4
Description
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham and Matthew Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.